Effect of cytokine-induced killer cells combined with dendritic cells on the survival rate and expression of 14-3-3ζ and p-Bad proteins in Lewis lung cancer cell lines

被引:5
作者
Hou, Yang [1 ]
Zang, Dongyu [2 ]
Li, Xiaoming [3 ]
Li, Fuzhi [2 ]
机构
[1] Jinzhou Med Univ, Life Sci Inst, Jinzhou 121001, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Affiliated Hosp 3, Dept Thoraxes Surg, 40 Sect 3,Songpo Rd, Jinzhou 121001, Liaoning, Peoples R China
[3] Jinzhou Med Univ, Dept Histol & Embryol, Jinzhou 121001, Liaoning, Peoples R China
关键词
cytokine-induced killer cells; dendritic cells; Lewis lung cancer cell; phosphorylated-Bad; PHOSPHO-BAD; IMMUNOTHERAPY; APOPTOSIS; PHOSPHORYLATION; COMBINATION; ABLATION; THERAPY; VACCINE;
D O I
10.3892/ol.2018.8834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, the function and mechanism of cytokine-induced killer cells (CIK) combined with dendritic cells (DC-CIK) were examined in Lewis lung cancer (LLC) cells. Co-culture of CIK dendritic cells (DC) in vitro was used to investigate their proliferation and the antitumor effects on LLC cells. DC and CIK cells were collected from healthy human peripheral blood mononuclear cells and co-cultured as an experimental group, while LLC cells were cultured alone as a control group. Cell morphology was observed by an inverted microscope and an MTT assay was utilized to detect the proliferation of LLC cells. Expression of 14-3-3 and p-Bad were measured by western blot analysis. Compared with the control group, treatment of LLC cells with DC-CIK resulted in decreased cell adherence, reduced cell proliferation and abnormal morphological changes. Additionally, DC-CIK treatment of LLC cells resulted in the decreased expression of 14-3-3 and p-Bad protein in LLC cells, which may provide important information pertaining to the possible mechanism of DC-CIK-induced antitumor activity against LLC cells. The present study provides a theoretical and experimental basis for the clinical treatment of DC-CIK cell co-culture.
引用
收藏
页码:1815 / 1820
页数:6
相关论文
共 35 条
[21]   Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel [J].
Rong, F. ;
Li, W. ;
Chen, K. ;
Li, D. M. ;
Duan, W. M. ;
Feng, Y. Z. ;
Li, F. ;
Zhou, X. W. ;
Fan, S. J. ;
Liu, Y. ;
Tao, M. .
NEOPLASMA, 2012, 59 (05) :541-550
[22]   Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J].
Schiller, JH ;
Harrington, D ;
Belani, CP ;
Langer, C ;
Sandler, A ;
Krook, J ;
Zhu, JM ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02) :92-98
[23]   Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response [J].
Shan, Chan-Chan ;
Shi, Liang-Rong ;
Ding, Mei-Qian ;
Zhu, Yi-Bei ;
Li, Xiao-Dong ;
Xu, Bin ;
Jiang, Jing-Ting ;
Wu, Chang-Ping .
ONCOLOGY LETTERS, 2015, 9 (04) :1549-1556
[24]   How I Do It Radiofrequency Ablation and Cryoablation of Lung Tumors [J].
Sharma, Amita ;
Moore, William H. ;
Lanuti, Michael ;
Shepard, Jo-Anne O. .
JOURNAL OF THORACIC IMAGING, 2011, 26 (02) :162-174
[25]   Immunotherapy in the treatment of non-small cell lung cancer [J].
Sundar, Raghav ;
Soong, Richie ;
Cho, Byoung-Chul ;
Brahmer, Julie R. ;
Soo, Ross A. .
LUNG CANCER, 2014, 85 (02) :101-109
[26]   14-3-3 proteins as potential oncogenes [J].
Tzivion, Guri ;
Gupta, Vinita Singh ;
Kaplun, Ludmila ;
Balan, Vitaly .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (03) :203-213
[27]   Remarkable regression of a lung recurrence from an undifferentiated embryonal sarcoma of the liver treated with a DC vaccine combined with immune cells: A case report [J].
Xie, Shangyun ;
Wu, Xiao ;
Zhang, Guoliang ;
Xu, Ke ;
Bian, Xiaoshan ;
Zhang, Shufang ;
Ye, Yongqing .
CELLULAR IMMUNOLOGY, 2014, 290 (02) :185-189
[28]   Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients [J].
Yang, Lili ;
Ren, Baozhu ;
Li, Hui ;
Yu, Jinpu ;
Cao, Shui ;
Hao, Xishan ;
Ren, Xiubao .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (01) :65-73
[29]   Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BGL-X(L) [J].
Zha, JP ;
Harada, H ;
Yang, E ;
Jockel, J ;
Korsmeyer, SJ .
CELL, 1996, 87 (04) :619-628
[30]   14-3-3 proteins as potential therapeutic targets [J].
Zhao, Jing ;
Meyerkord, Cheryl L. ;
Du, Yuhong ;
Khuri, Fadlo R. ;
Fu, Haian .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2011, 22 (07) :705-712